Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 15, 2024Blood AdvancesOpen Access

Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

RWRomy E. van WeelderenEmma KinderziekenhuisCHChristine J. HarrisonNewcastle UniversityKKKim KleinUniversity Medical Center Utrecht

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Weelderen et al. (2024) studied this question.

synapsesocial.com/papers/68e6f047b6db64358766ae6fhttps://doi.org/10.1182/bloodadvances.2023011771
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Balancing benefit and burden: treatment intensification in paediatric KMT2A rearrangements acute myeloid leukaemia2025
  2. 2Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study2024 · 34 citations
  3. 3Clinicomolecular features and clonal evolution of KMT2A-PTD AML: prognostic impact of concurrent FLT3-ITD under 2022 ELN risk stratification2026
  4. 4Prognostic impact of KMT2A-PTD in acute myeloid leukemia in the NGS era: a multicenter retrospective study2026
  5. 5Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience2021 · 60 citations